International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery Interventional Pulmonology

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-20-09-2021-937
Total View : 378

Abstract : Stunting is a condition resulting from poor nutrition or repeated infections that have a greater risk of contracting a disease to death. There are several risk factors, namely birth weight, short birth length, nutritional intake level, previous disease history (recurrent infections), parental education level, sanitation and drinking water conditions, and family economic status. This study aims to analyze the determinants of stunting in children. The design of this study is a cross-sectional study where the type of research that emphasizes the time of measurement/observation of independent and dependent variable data only once at a time, was carried out in Singkuang and Huta Godang Villages in Mandailing Natal Regency. We carried the time of the study out in July 2019. The target population in this study were all children aged 6 months to 5 years. In this study, poor nutritional intake, low parental education, and poor drinking water sources can increase the risk of stunting in children under five years of age. The determinants of stunting include birth weight and length, nutritional intake level, parental education level, family economic status, sanitation conditions, and clean drinking water sources, which together affect the incidence of stunting (p<0.005, each). To reduce the incidence of stunting, it is necessary to make efforts to improve each of the determinants including babies with low birth weight and length, inadequate levels of nutritional intake, low parental education levels, low family economic status, and conditions of sanitation and water sources. bad clean drinking..
Full article
International Medical Journal
Journal ID : IMJ-20-09-2021-936
Total View : 346

Abstract : Sino nasal malignancies account for about 0.2-0.8% of all malignancies and undifferentiated carcinoma is a rare tumour of the sino-nasal tract, with extremely poor prognosis. Although the overall survival is about 22-43% at 5yrs with as many as 65% of the patients developing distant metastasis, combined multimodality treatment is the best management option available at present. We are reporting a case of sinonasal undifferentiated carcinoma which we managed by surgery followed by post operative chemotherapy and radiotherapy..
Full article
International Medical Journal
Journal ID : IMJ-18-09-2021-935
Total View : 432

Abstract : The development of HF following an MI is a high-risk occurrence that will negatively impact the patient's long-term outcome. Though timely reperfusion is the most effective treatment to preserve the myocardium, medical therapy has a crucial role in avoiding or even correcting LV failure. In these individuals, newer medical therapies (ARNI and SGLT2i) have a potential role to play. Although initial evidence showed safety to use, reliable data regarding the added benefit is lacking..
Full article
International Medical Journal
Journal ID : IMJ-16-09-2021-933
Total View : 433

Abstract :

Schwannoma is a rare type of tumor that forms in the nervous system. Schwannoma grows from cells called Schwann cells. Schwann cells protect and support the nerve cells of the nervous system. Schwannoma tumours are often benign, which means they are not cancerous. But, in rare cases, they can become cancer. Schwannoma are a rare disease, affecting fewer than 200,000 people. Schwannoma is the most common type of peripheral nerve tumors in adults. Schwannoma can occur in people of all ages. A schwannoma typically comes from a single bundle (fascicle) within the main nerve and displaces the rest of the nerve. When the tumor grows larger, more fascicles are affected, making removal more difficult. In general, a schwannoma grows slowly. About 4% of head and neck schwannomas present as a Sinonasal schwannoma making them an extremely rare group of tumours [1]. Here we report a case of sinonasal schwannoma in a 60-year-old female who presented to our OPD with complaints of nasal obstruction Complete excision of the tumor was achieved by using endoscopic approach. The mass was removed successfully without any postoperative complication and there was no recurrence within a year of follow up.

.
Full article
International Medical Journal
Journal ID : IMJ-15-09-2021-931
Total View : 345

Abstract : Cancer is a disease in humans that can cause death it has become one of the world's major health issues. One of the causes of cancer is an infectious agent. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are infectious agents that can cause liver cancer. GLOBOCAN 2018 provides an overview of the incidence and mortality rates for 36 forms of cancer in numerous nations, including ASEAN countries, including liver cancer caused by both HBV and HCV. This research aims to estimate the premature mortality cost of liver cancer caused by infectious agents (HBV and HCV) in ASEAN countries. This research is a descriptive study, based on data from the GLOBOCAN 2018 database on the incidence and mortality rates of liver cancer in ASEAN countries, divided into gender and age categories. Relative Risk (RR) from liver cancer and prevalence from each HBV and HCV for calculating Population Attributable Fractions (PAFs) were obtained by reviewing previous studies about liver cancer and also HBV and HCV. Premature mortality cost was determined by multiplying the mortality of liver cancer caused by HBV and HCV infection, the life expectancy of each ASEAN country, and the average income of each ASEAN country. Thailand has the highest premature mortality cost for male group for HBV-related liver cancer (US$ 49.32 million) and Vietnam has the highest cost for HCV infection (US$ 136.14 million). Premature mortality cost in Thailand (US$ 21.26 million) has the highest premature mortality cost for HBV-related liver cancer in females, whereas Vietnam (US$ 39.73 million) has the highest cost for HCV-related liver cancer. According to the findings of this study, the burden of liver cancer caused by HBV and HCV in ASEAN could have a significant impact on health costs and quality of life. To lower the prevalence and mortality of liver cancer caused by HBV and HCV in the future, preventing the risk factors that cause the disease should be a top priority in the national health strategy. This study has brought the burden of liver cancer to ASEAN, which will be useful in developing health policies and plans to reduce liver cancer's prevalence and death..
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//